ProKidney – Trademark Portfolio
Entity Type: 99
ProKidney holds 9 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 9 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 4 Nice Classification classes. Currently, 4 trademarks are registered and 3 are pending. Notable registered marks include REACT and PROKIDNEY. The owner is based in GRAND CAYMAN.
10 MARKET STREET, 688 CAMANA BAY
GRAND CAYMAN KY1-9006 , KY
Showing of trademarks Trademarks
Trademark Classifications
ProKidney's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does ProKidney have?
ProKidney has 9 U.S. trademarks filed with the USPTO. Of these, 4 registered, 3 pending, 2 abandoned.
What trademark classes does ProKidney file in?
ProKidney files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 1 (Chemicals), Class 44 (Medical Services). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are ProKidney's most well-known trademarks?
ProKidney's registered trademark portfolio includes well-known marks such as REACT and PROKIDNEY. These are among 4 currently registered trademarks in the portfolio.
What is ProKidney's trademark registration success rate?
ProKidney has a 67% trademark registration rate, with 4 out of 6 resolved applications resulting in successful registration. Currently, 3 applications are pending review.